Basic Caverta Information

• INN (International Nonproprietary Name): Sildenafil
• Brand Names Available In United Kingdom: Viagra (Pfizer); Revatio (Pfizer); authorised generics may be available. Caverta (Sun Pharma) is marketed in India and South Asia and UK authorisation is not specified.
• ATC Code: G04BE03
• Forms & Dosages: Tablets 25 mg, 50 mg, 100 mg; oral suspension 10 mg/mL (PAH); tablet 20 mg for PAH formulations.
• Manufacturers In United Kingdom: not specified
• Registration Status In United Kingdom: not specified
• OTC / Rx Classification: Prescription (Rx) only

Latest Research Highlights UK And EU 2022–2025 — Evidence Summary, Safety Signals And Comparative Outcomes

Patients and clinicians ask whether recent studies change how sildenafil is used in the UK.

Contemporary UK and EU research, including RCTs and observational pooled analyses from 2022–2024, reaffirm sildenafil’s consistent efficacy for erectile dysfunction and benefit in pulmonary arterial hypertension when used for the licensed indications.

Key clinical notes include a rapid onset for ED, typically 30–60 minutes, and clinically meaningful improvements in International Index of Erectile Function scores across mild‑to‑moderate ED cohorts.

For PAH there is replicated benefit in exercise capacity, typically measured by improvements in six‑minute walk distance under specialist supervision.

Safety signals remain stable: common adverse effects are headache, flushing, nasal congestion, dyspepsia and transient visual changes, while serious cardiovascular events are rare but require risk assessment in high‑risk patients.

MHRA Yellow Card summaries emphasise the danger of interactions with nitrates and report isolated cases of priapism.

Clinical Effectiveness In The UK — NHS Outcomes And Patient‑Reported Results

Many men wonder how sildenafil performs in everyday NHS practice compared with trial settings.

NHS clinic and audit data show sildenafil provides functional benefit for many men with erectile dysfunction when prescribed alongside sexual counselling and management of comorbidities such as diabetes, vascular disease and mental health issues.

NHS practice typically follows MHRA‑aligned dosing with lower starting doses for elderly or comorbid patients and 50–100 mg as the effective dose range for most adults.

Patient‑reported outcome measures in NHS portals and community sexual health clinics indicate improved satisfaction, but around a third report suboptimal response without dose adjustment or a switch to tadalafil or avanafil.

For pulmonary arterial hypertension, PAH formulations such as Revatio improve exercise capacity when managed by a specialist team.

• NHS Treatment Pathway Steps: assessment of ED, address reversible causes, initiate counselling, start sildenafil at appropriate dose, and review response.
• Patient‑Reported Barriers: cost, stigma, side effects and variability in response.

Indications And Expanded Uses — MHRA‑Approved And Off‑Label Practice In UK Care

People frequently ask if sildenafil is used for anything beyond ED and PAH.

MHRA‑approved uses in the UK align with EMA/FDA: oral sildenafil for erectile dysfunction and specific PAH formulations such as Revatio for pulmonary arterial hypertension.

Off‑label prescribing occurs under specialist oversight for limited vascular disorders, for example investigational uses in Raynaud’s phenomenon, but routine off‑label use is uncommon.

PAH dosing differs from ED dosing and is specialist‑led, typically 20 mg three times daily for licensed PAH formulations.

Approved use

ED (oral sildenafil formulations)

Specialist use

PAH (Revatio/Liqrev formulations; scheduled dosing)

Off‑label

Investigational vascular uses with limited evidence and specialist oversight.

Composition And Brand Landscape — Active Ingredient, UK Brands, And Generics

Patients want to know whether Caverta is the same as Viagra.

The active molecule is sildenafil citrate, the INN sildenafil, and the same active substance is used across brands and generics.

Global brands include Caverta (Sun Pharma, India/South Asia), Viagra and Revatio (Pfizer) and multiple generics; strengths commonly sold are 25 mg, 50 mg and 100 mg tablets and PAH oral suspensions at 10 mg/mL.

• Strengths/Forms: 25 mg, 50 mg, 100 mg tablets; 10 mg/mL oral suspension; 20 mg PAH tablet.
• Brand Notes: Caverta is widely used in India and neighbouring regions; UK pharmacies must follow MHRA import and sourcing rules if supplying non‑UK brands.

Contraindications And Special Precautions — High‑Risk Groups And Daily‑Life Restrictions

People commonly worry whether sildenafil is safe with their existing heart medicines.

Absolute contraindications include concurrent nitrate therapy such as nitroglycerin or isosorbide dinitrate and known hypersensitivity to sildenafil or excipients.

Severe hypotension or a recent myocardial infarction or stroke are also exclusions.

Relative contraindications that require monitoring include unstable cardiovascular disease, severe hepatic or renal impairment, retinitis pigmentosa and penile anatomical abnormalities.

• Absolute Contraindications: nitrates; severe hypotension; recent MI/stroke; allergy to sildenafil.
• Relative Contraindications: unstable cardiac disease; severe liver or kidney disease; retinitis pigmentosa.

Practical daily‑life advice: avoid heavy alcohol before dosing as it delays absorption and may reduce response.

Avoid high‑fat meals for the same reason and caution patients about driving if dizziness or visual disturbance occurs.

MHRA Yellow Card reporting is encouraged for suspected adverse reactions.

Dosage Guidelines — NHS‑Aligned Regimens And Special Population Adjustments

Patients want clear guidance on how and when to take sildenafil.

Standard ED dosing is to take sildenafil 30–60 minutes before sexual activity, with a typical adult dose range of 50–100 mg and a maximum of 100 mg in 24 hours.

Start at lower doses for elderly patients and for those taking interacting medicines, commonly 25–50 mg initially.

PAH dosing for specialist brands is 20 mg three times daily, and oral suspension formulations (10 mg/mL) are used for weight‑based paediatric dosing.

Interactions Overview — Foods, Substances, And MHRA Yellow Card‑Reported Drugs

It is essential to check interactions before starting sildenafil.

Concurrent use with nitrates is an absolute contraindication because of the risk of serious hypotension.

Potent CYP3A4 inhibitors, such as ritonavir and some azole antifungals, raise sildenafil levels and require dose reduction and monitoring.

CYP3A4 inducers like rifampicin may lower sildenafil effectiveness.

Alcohol and high‑fat meals delay absorption and can postpone onset.

• High‑Risk Drug List: nitrates; potent CYP3A4 inhibitors (e.g. ritonavir, ketoconazole); consider dose reduction.
• Food/Substance Interactions: heavy alcohol; fatty meals; St John’s wort may reduce levels.

MHRA Yellow Card reports highlight interactions with cardiovascular medicines and rare severe hypotension events.

Cultural Perceptions And Patient Habits In The UK — Forums, Pharmacy Trust And Access Patterns

Many patients search forums and expect discretion when buying ED medicine.

UK patients often combine NHS 111 guidance, Patient.info and peer forums with pharmacist consultations when seeking erectile dysfunction treatment.

Community pharmacists and major chains such as Boots, LloydsPharmacy and Superdrug are trusted for confidential advice and discreet supply.

Telehealth services and online pharmacies have increased private prescribing, but stigma persists, especially among older men and some ethnic groups, which affects disclosure and uptake.

Cost sensitivity drives some people to look for imported generics like Caverta online, despite variable licensing and potential regulatory risk.

• Common Patient Pathways: GP or sexual health clinic referral, pharmacist consultation, private clinic or telehealth prescription.
• Barriers To Care: stigma, cost, side effects, and concerns about legitimacy of online supplies.

Availability And Pricing Patterns — UK Retail, NHS Prescribing And Regional Differences

People often ask whether sildenafil is available on the NHS and how prices compare to private purchase.

Sildenafil is prescription‑only in the UK and is available on NHS prescription for patients with a clinical need, and through private prescriptions and licensed online pharmacies.

Regional differences arise because prescription charges vary between England and the devolved nations, affecting out‑of‑pocket cost for private buyers.

Private prices vary by brand and pack size, with imported generics often offered at lower prices but carrying regulatory and safety considerations.

In our online pharmacy, caverta is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.

Comparable Medicines And Patient Preferences — Alternatives, Pros/Cons And Switching Rationale

When sildenafil is ineffective or unsuitable, patients ask what else is available.

Main PDE5 alternatives include tadalafil, vardenafil and avanafil, each with different onset and duration profiles that suit individual needs.

Tadalafil offers a longer duration, up to 36 hours, and a daily low‑dose option for some patients who prefer spontaneity.

Vardenafil and avanafil may have a faster onset in some people and differ slightly in side‑effect profiles.

For PAH, endothelin receptor antagonists such as bosentan and ambrisentan are alternative classes used under specialist teams.

• Checklist For Choice: desired onset, duration, comorbidities, interactions, side effects and cost.
• Switching Guidance: try alternative PDE5 inhibitors if sildenafil is ineffective or poorly tolerated, under clinician review.

Faq — Common NHS Patient Questions

Q1: Can I get Caverta on the NHS?

A1: NHS prescriptions will usually provide licensed formulations such as branded sildenafil or authorised generics when clinically appropriate; Caverta, marketed by Sun Pharma, is predominantly sold in India and South Asia and UK approval is not specified.

Q2: Is sildenafil safe with my heart medication?

A2: Sildenafil must not be taken with nitrates and other cardiovascular medicines should be reviewed by a prescriber; always disclose all medicines to your GP or pharmacist.

Q3: How soon will it work and how often can I take it?

A3: Sildenafil typically works in 30–60 minutes for ED and should not be taken more than once every 24 hours, with a maximum 100 mg daily dose for ED.

Q4: Are online imports safe?

A4: Licensed UK pharmacies and MHRA‑approved supply routes are the safest sources; imports can be cheaper but carry the risk of unregulated supply and uncertain authorisation.

• Quick Checklist Before Taking Sildenafil: confirm no nitrates, inform prescriber about heart disease, avoid heavy alcohol and high‑fat meals, and follow recommended dosing.

Guidelines For Proper Use — UK Pharmacist Counselling Style And NHS Support

Patients expect clear, practical counselling from the pharmacist before starting sildenafil.

Pharmacist consultations should confirm the indication and medical history, including cardiac history and nitrate use, and review concomitant medicines for interactions.

Advise timing: take sildenafil 30–60 minutes before sexual activity and note that sexual stimulation is required for effect.

Explain dose limits: typical effective doses are 50–100 mg with a maximum of 100 mg in 24 hours for ED; PAH formulations are 20 mg three times daily under specialist care.

Discuss common side effects and advise Yellow Card reporting for suspected adverse reactions.

Counselling Steps

Confirm history; review meds; advise dosing, timing and side effects; provide signposting to NHS 111, sexual health clinics and GP.

Red Flags For Urgent Review

Chest pain, severe shortness of breath, prolonged erection over 4 hours (priapism), sudden vision loss.

Delivery Across United Kingdom